Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Brain Lesion”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Not applicableStudy completedNCT00617383
What this trial is testing

AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
The University of Texas Health Science Center, Houston 3
Not applicableStudy completedNCT03438357
What this trial is testing

Evaluation of an Automatic Segmentation Software (Pixyl.Neuro) to Track Lesions in Multiple Sclerosis Patients Via Cerebral MRI

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
Centre Hospitalier Universitaire de Nīmes 200
Testing effectiveness (Phase 2)UnknownNCT04742400
What this trial is testing

Tolebrutinib, a Brain-penetrant Bruton's Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 12
Not applicableStudy completedNCT03268239
What this trial is testing

Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions

Who this might be right for
Magnetic Resonance ImagingCentral Nervous SystemBrain+2 more
Fondation Ophtalmologique Adolphe de Rothschild 180
Testing effectiveness (Phase 2)UnknownNCT03356769
What this trial is testing

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Who this might be right for
Tuberous Sclerosis ComplexAspirinEpilepsy+2 more
Peking Union Medical College Hospital 98
Not applicableLooking for participantsNCT06955832
What this trial is testing

Early Identification of Brain Lesions in Multiple Sclerosis With Phase Sensitive Inversion Recovery MRI

Who this might be right for
Multiple Sclerosis
Benha University 30
Testing effectiveness (Phase 2)Ended earlyNCT02038049
What this trial is testing

Assess the Effect of a Single Infusion of VAY736 on Disease Activity in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapse Remitting Multiple Sclerosis
Novartis Pharmaceuticals 8
Not applicableStudy completedNCT04220814
What this trial is testing

Evaluation of the Impact of Lesions of the Motor and Proprioceptive Brain and Pan-medullary Pathways on Their Clinically and Electrophysiologically Assessed Function in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Rennes University Hospital 94
Not applicableEnded earlyNCT02967380
What this trial is testing

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

Who this might be right for
Adult Anaplastic (Malignant) MeningiomaAdult Anaplastic AstrocytomaAdult Anaplastic Ependymoma+22 more
University of Southern California 14
Testing effectiveness (Phase 2)Ended earlyNCT02466074
What this trial is testing

Augmenting Cerebral Blood Flow to Treat Established Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
The University of Texas Health Science Center, Houston 5
Not applicableEnded earlyNCT03660618
What this trial is testing

LSFG-SKIN, Laser Speckle Flowgraphy

Who this might be right for
HypertensionHeart FailureVascular Ischemia+13 more
Randy Kardon 1
Not applicableWithdrawnNCT04344626
What this trial is testing

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

Who this might be right for
EpilepsyFocal Cortical DysplasiaTuberous Sclerosis+7 more
University of California, Los Angeles
Testing effectiveness (Phase 2)Study completedNCT06322342
What this trial is testing

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Who this might be right for
Central Nervous System (CNS) LesionsBrain MetastasesBrain Neoplasms+22 more
Reveal Pharmaceuticals Inc. 18
Early research (Phase 1)Looking for participantsNCT05451251
What this trial is testing

Deep Brain Stimulation for Refractory Trigeminal Neuralgia with a Pontine Lesion

Who this might be right for
Trigeminal Neuralgia
Université de Sherbrooke 6
Not applicableStudy completedNCT07687693
What this trial is testing

Simultaneous T2-FLAIR and T1 Brain MRI With ENRAGED FLAIR in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Region Stockholm 11
Not applicableStudy completedNCT05718947
What this trial is testing

Ultra-high-field Brain MRI in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Zuyderland Medisch Centrum 10
Not applicableLooking for participantsNCT07444047
What this trial is testing

MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)Cerebral Small Vessel Diseases
Oslo University Hospital 1,000
Not applicableEnded earlyNCT01836055
What this trial is testing

Imaging Multiple Sclerosis Lesions Using Magnevist and Gadavist

Who this might be right for
Multiple Sclerosis
Wayne State University 19
Testing effectiveness (Phase 2)Looking for participantsNCT05359653
What this trial is testing

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Who this might be right for
Multiple Sclerosis (MS)Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+4 more
University of California, San Francisco 74
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06065670
What this trial is testing

Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy

Who this might be right for
Demyelinating DiseasesDemyelination; Corpus CallosumMultiple Sclerosis Brain Lesion+2 more
University of California, San Francisco 44
Next Page